Market Research Expert

Global SNP Genotyping and Analysis Market to Benefit from Growing Awareness Pertaining to Personalized Medicine

Press Release   •   Jan 13, 2017 04:55 EST

The increasing demand for SNP genotyping and analysis from the breeding and livestock industry has significantly driven the global SNP genotyping and analysis market in recent years. Further, the global market is likely to benefit from the rising incidence of genetic diseases and growing awareness pertaining to personalized medicine.

The research report segments the global SNP genotyping and analysis market on the basis of technologies applied, application, and regional distribution.

Request a PDF Brochure with Report Analysis: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=432

SNP gene-chips and microarrays, SNP by pyrosequencing, taqman allelic discrimination, MassARRAY MALDI-TOF, and AB SNPlex are the major technologies applied in the worldwide SNP genotyping and analysis market.

Pharmacogenomics and pharmaceuticals, agricultural biotechnology, diagnostic research, and breeding and livestock are the key end users of SNP genotyping and analysis.

Regionally, the global SNP genotyping and analysis market is segmented into North America, Asia Pacific, Europe, and the Rest of the World.

This research report on the global SNP genotyping and analysis market aims to provide market participants, consultants, and stakeholders a clear picture of the global scenario. The report employs various analytical tools such as Porter’s five forces, market feasibility, and SWOT analysis to present a comprehensive overview of the global market for SNP genotyping and analysis.

The global SNP genotyping and analysis market stood at US$2.3 bn in 2012. Aided by declining prices of sequencing, a factor that has consequently trigged R&D activities in SNP genotyping and analysis, the market is likely to exhibit a CAGR of 21.80% over the period from 2013 to 2019 and reach US$9.4 bn by the end of the forecast period.

The SNP genotyping and analysis market in North America leads the global market as the region has a first-mover advantage in various significant SNP technologies. The rising awareness and augmenting demand for SNP genotyping from the animal breeding industry and the pharmacogenomics sector is likely to propel this regional market during the forecast period.

On the other hand, the Asia Pacific SNP genotyping and analysis market is projected to report the highest CAGR of 23.1% over the forecast period on account of advancements in the healthcare infrastructure in the region.

The global market for SNP genotyping and analysis is experiencing a phase of immense growth at present. However, the lack of appropriate reimbursement policies is hampering the market from growing steadily and is expected to create a severe challenge for this market over the forecast period.

Affymetrix Inc., Fluidigm, Douglas Scientific LLC, Illumina Inc., PREMIER Biosoft, Life Technologies Corp., Sequenom Inc., and ThermoFisher Scientific are the key players in the global SNP genotyping and analysis market. A rise in the demand for cost-efficient genotyping solutions is likely to provide significant opportunities for the market participants during the forecast period.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.